A Study of LY2979165 and LY2140023 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions
Healthy Volunteers
Interventions
DRUG

LY2979165

Capsules administered orally

DRUG

LY2140023

Tablets administered orally

OTHER

Placebo

Administered orally

OTHER

Ketamine

Administered intravenously (IV)

Trial Locations (2)

SE5 8AF

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., London

SE 1 1YR

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., London

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT01524237 - A Study of LY2979165 and LY2140023 in Healthy Volunteers | Biotech Hunter | Biotech Hunter